1. Home
  2. JFBR vs ONCO Comparison

JFBR vs ONCO Comparison

Compare JFBR & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jeffs' Brands Ltd

JFBR

Jeffs' Brands Ltd

HOLD

Current Price

$3.01

Market Cap

1.4M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$0.96

Market Cap

1.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFBR
ONCO
Founded
2017
2018
Country
Israel
United States
Employees
11
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JFBR
ONCO
Price
$3.01
$0.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
445.0K
4.0M
Earning Date
03-31-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
N/A
$815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.09
52 Week High
$7.87
$7.65

Technical Indicators

Market Signals
Indicator
JFBR
ONCO
Relative Strength Index (RSI) 46.37 53.17
Support Level $0.47 $0.49
Resistance Level $3.70 $1.87
Average True Range (ATR) 0.34 0.10
MACD -0.26 0.03
Stochastic Oscillator 35.58 63.67

Price Performance

Historical Comparison
JFBR
ONCO

About JFBR Jeffs' Brands Ltd

Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank, Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon to identify existing stores, niches, and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: